Journal of Medical Economics, Volume 12, Issue 2 (2009)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Journal of Medical Economics, Volume 12, Issue 2 (2009)

See all volumes and issues
Vol 27, 2024 Vol 26, 2023 Vol 25, 2022 Vol 24, 2021 Vol 23, 2020 Vol 22, 2019 Vol 21, 2018 Vol 20, 2017 Vol 19, 2016 Vol 18, 2015 Vol 17, 2014 Vol 16, 2013 Vol 15, 2012 Vol 14, 2011 Vol 13, 2010 Volume 12, 2009 Vol 11, 2008 Vol 10, 2007 Vol 9, 2006 Vol 8, 2005 Vol 7, 2004 Vol 6, 2003 Vol 5, 2002 Vol 4, 2001 Vol 3, 2000 Vol 2, 1999 Vol 1, 1998
Download citations Download PDFs Download issue

Original Research

Article
Less frequent dosing of erythropoiesis stimulating agents in patients undergoing dialysis: a European multicentre cost study
Michel Burnier, Jacques A Douchamps, Ann Tanghe, Jan Demey, Louise Perrault, Claire E Foster & Sean Robbins
Pages: 77-86
Published online: 07 May 2009
AbstractforLess frequent dosing of erythropoiesis stimulating agents in patients undergoing dialysis: a European multicentre cost study | Full Text | References | PDF (864.7 KB)
  • 451 Views
  • 8 CrossRef citations
  • 0Altmetric
Free Access
Article
Comparison of treatment costs in inadequately controlled type 2 diabetes in Germany based on the APOLLO trial with insulin glargine
Reinhard G. Bretzel, Franz-Werner Dippel, Thomas Linn & Aileen Rae Neilson
Pages: 87-97
Published online: 28 May 2009
AbstractforComparison of treatment costs in inadequately controlled type 2 diabetes in Germany based on the APOLLO trial with insulin glargine | Full Text | References | PDF (711.1 KB)
  • 340 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access
Article
Predicting time to nursing home placement based on activities of daily living scores – a modelling analysis using data on Alzheimer's disease patients receiving rivastigmine or donepezil
Hind T Hatoum, Simu K Thomas, Swu-Jane Lin, Roger Lane & Roger Bullock
Pages: 98-103
Published online: 04 Jun 2009
AbstractforPredicting time to nursing home placement based on activities of daily living scores – a modelling analysis using data on Alzheimer's disease patients receiving rivastigmine or donepezil | Full Text | References | PDF (586.5 KB)
  • 798 Views
  • 34 CrossRef citations
  • 0Altmetric
Free Access

Original Article

Article
Healthcare costs associated with treatment of bipolar disorder using a mood stabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone
Yonghua Jing, Edward Kim, Min You, Andrei Pikalov & Quynh-Van Tran
Pages: 104-113
Published online: 16 Jun 2009
AbstractforHealthcare costs associated with treatment of bipolar disorder using a mood stabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone | Full Text | References | PDF (660.6 KB) | Supplemental
  • 727 Views
  • 14 CrossRef citations
  • 0Altmetric
Free Access

Original Articles

Article
Cost-effectiveness of insulin detemir compared with neutral protamine Hagedorn insulin in patients with type 1 diabetes using a basal-bolus regimen in five European countries
Manuela Helena Gschwend, Mark Aagren & William J Valentine
Pages: 114-123
Published online: 23 Jun 2009
AbstractforCost-effectiveness of insulin detemir compared with neutral protamine Hagedorn insulin in patients with type 1 diabetes using a basal-bolus regimen in five European countries | Full Text | References | PDF (659.7 KB)
  • 723 Views
  • 21 CrossRef citations
  • 0Altmetric
Free Access

Original Research

Article
Treatment persistence, healthcare utilisation and costs in adult patients with major depressive disorder: a comparison between escitalopram and other SSRI/SNRIs
Eric Q. Wu, Paul E. Greenberg, Elaine Yang, Andrew P. Yu, Rym Ben-Hamadi & M. Haim Erder
Pages: 124-135
Published online: 01 Jul 2009
AbstractforTreatment persistence, healthcare utilisation and costs in adult patients with major depressive disorder: a comparison between escitalopram and other SSRI/SNRIs | Full Text | References | PDF (603.8 KB)
  • 807 Views
  • 13 CrossRef citations
  • 0Altmetric
Free Access
Article
Costs and quality of life effects of the first year of renal replacement therapy in one Finnish treatment centre
Taru Hallinen, Erkki J. O. Soini, Janne A. Martikainen, Risto Ikäheimo & Olli-Pekka Ryynänen
Pages: 136-140
Published online: 01 Jul 2009
AbstractforCosts and quality of life effects of the first year of renal replacement therapy in one Finnish treatment centre | Full Text | References | PDF (575.4 KB)
  • 444 Views
  • 7 CrossRef citations
  • 0Altmetric
Free Access

Review

Article
Adherence to guidelines for sensitivity analysis: cost-effectiveness analyses of dual oral antiplatelet therapy
Josephine A. Mauskopf, Kristina S. Boye, Claude Schmitt, Patrick McCollam, Julie Birt, Melissa D. Juniper & Ameet Bakhai
Pages: 141-153
Published online: 24 Jul 2009
AbstractforAdherence to guidelines for sensitivity analysis: cost-effectiveness analyses of dual oral antiplatelet therapy | Full Text | References | PDF (571.9 KB) | Supplemental
  • 479 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access

Original Article

Article
Impact of neutropenic complications on short-term disability in patients with cancer receiving chemotherapy
Xue Song, Robert Fowler, Kimberly Ruiz, Dana Hurley & Richard L. Barron
Pages: 154-163
Published online: 13 Jul 2009
AbstractforImpact of neutropenic complications on short-term disability in patients with cancer receiving chemotherapy | Full Text | References | PDF (608.2 KB)
  • 242 Views
  • 6 CrossRef citations
  • 0Altmetric
Free Access

Original Research

Article
Costs of haematological adverse events in chronic myeloid leukaemia patients: a retrospective cost analysis of the treatment of anaemia, neutropenia and thrombocytopenia in patients with chronic myeloid leukaemia
Clazien Bouwmans, Jeroen Janssen, Peter Huijgens & Carin Uyl-de Groot
Pages: 164-169
Published online: 17 Jul 2009
AbstractforCosts of haematological adverse events in chronic myeloid leukaemia patients: a retrospective cost analysis of the treatment of anaemia, neutropenia and thrombocytopenia in patients with chronic myeloid leukaemia | Full Text | References | PDF (535.5 KB)
  • 1141 Views
  • 12 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

The efficiency of TAVI in intermediate and low-risk Japanese patients.
Panagiotis Petrou
Editorial | Published online: 25 May 2024
Open Access
Cost-effectiveness of empagliflozin as add-on to standard of care for chronic kidney disease management in the United Kingdom
Mafalda Ramos et al.
Article | Published online: 17 May 2024
Open Access
Estimated impact and value of blood-based colorectal cancer screening at varied adherence compared with stool-based screening
John B. Kisiel et al.
Article | Published online: 13 May 2024
Open Access
Balancing innovation and ethics in AI governance for health technology assessment
João L. Carapinha et al.
Editorial | Published online: 13 May 2024
Open Access
View all latest articles